Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Brilacidin OM ph3 hasn't started yet due to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 542
Posts 24,564
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/13/2019 4:11:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/2/2019 4:29:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2019 9:30:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 10:16:34 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:19:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2019 7:33:24 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/10/2019 7:32:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/8/2019 4:05:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/31/2019 4:18:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2019 4:17:16 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/22/2019 12:08:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2019 4:32:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2018 5:02:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2018 7:07:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2018 7:02:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 7:16:54 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2018 5:03:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/24/2018 7:01:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2018 4:17:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2018 6:20:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2018 10:56:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2018 6:54:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/9/2018 6:53:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:36:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:33:20 PM
KarinCA Member Level  Saturday, 06/01/19 05:51:19 PM
Re: To infinity and beyond! post# 264854
Post # of 271354 
Brilacidin OM ph3 hasn't started yet due to lack of funds. It's a cancer care trial that is greatly needed by both the patients and the shareholders. I hope Art and Leo are successful in thier endeavors in trying to sign a deal.... whatever size they can get at this point. Once first one is inked the next should be better.






In Reply to 'To infinity and beyond!'
This is precisely what tells you that B OM not good enough for P3 anytime soon. Such an unmet need and so easy to take. But ambiguous data and NO deal. 18 months after data.....

P3: it ain't happenin' anytime soon






To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist